Avanos Medical Net Worth
Avanos Medical Net Worth Breakdown | AVNS |
Avanos Medical Net Worth Analysis
Avanos Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Avanos Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Avanos Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Avanos Medical's net worth analysis. One common approach is to calculate Avanos Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Avanos Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Avanos Medical's net worth. This approach calculates the present value of Avanos Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Avanos Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Avanos Medical's net worth. This involves comparing Avanos Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Avanos Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Avanos Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Avanos Medical's net worth research are outlined below:
| Avanos Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 673.3 M. Net Loss for the year was (61.8 M) with profit before overhead, payroll, taxes, and interest of 378.3 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Avanos Medical Soars 7.2 percent Is Further Upside Left in the Stock - MSN |
Avanos Medical Quarterly Good Will |
|
Avanos Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Avanos Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Avanos Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Avanos Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Avanos Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avanos Medical backward and forwards among themselves. Avanos Medical's institutional investor refers to the entity that pools money to purchase Avanos Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Neuberger Berman Group Llc | 2024-09-30 | 1.1 M | Geode Capital Management, Llc | 2024-09-30 | 1.1 M | Tributary Capital Management, Llc | 2024-09-30 | 646.6 K | Prudential Financial Inc | 2024-09-30 | 586.7 K | Royal Bank Of Canada | 3124-09-30 | 580.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 523.5 K | Northern Trust Corp | 2024-09-30 | 502 K | Arrowstreet Capital Limited Partnership | 2024-09-30 | 454.9 K | Goldman Sachs Group Inc | 2024-09-30 | 418.4 K | Blackrock Inc | 2024-09-30 | 7 M | Vanguard Group Inc | 2024-09-30 | 5.3 M |
Follow Avanos Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 801.95 M.Market Cap |
|
Project Avanos Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.11) | (0.10) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.06) | (0.05) |
When accessing Avanos Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Avanos Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Avanos Medical's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Avanos Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Avanos Medical. Check Avanos Medical's Beneish M Score to see the likelihood of Avanos Medical's management manipulating its earnings.
Evaluate Avanos Medical's management efficiency
Avanos Medical has return on total asset (ROA) of 0.0208 % which means that it generated a profit of $0.0208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0177 %, meaning that it created $0.0177 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.10). At this time, Avanos Medical's Other Current Assets are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 627.7 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 181.9 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 30.51 | 32.46 | |
| Tangible Book Value Per Share | 4.95 | 5.47 | |
| Enterprise Value Over EBITDA | 26.51 | 27.84 | |
| Price Book Value Ratio | 0.97 | 1.45 | |
| Enterprise Value Multiple | 26.51 | 27.84 | |
| Price Fair Value | 0.97 | 1.45 | |
| Enterprise Value | 2 B | 2.3 B |
Leadership effectiveness at Avanos Medical is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue 1.3321 | Revenue | Quarterly Revenue Growth (0.01) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avanos Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avanos Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avanos Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Avanos Medical Corporate Filings
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 6th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F3 | 6th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Avanos Medical Earnings per Share Projection vs Actual
Avanos Medical Corporate Directors
| Patrick OLeary | Independent Director | Profile | |
| Julie Shimer | Independent Director | Profile | |
| William Hawkins | Independent Director | Profile | |
| Heidi Kunz | Independent Director | Profile |
Already Invested in Avanos Medical?
The danger of trading Avanos Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avanos Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avanos Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avanos Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.